Skip to content

Saphenous Nerve Block: Single Shot Versus Continuous Infusion to Supplement a Continuous Sciatic Nerve Block After Major Ankle Surgery

A Randomized Comparison of Single Injection vs. Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block in Postoperative Pain Treatment After Major Ankle Surgery: Clinical Outcome and Cost Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01445210
Enrollment
50
Registered
2011-10-03
Start date
2011-09-30
Completion date
2012-10-31
Last updated
2012-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Ankle Surgery

Keywords

Postoperative pain, Major ankle surgery, Continuous nerve block, Saphenous nerve, Ropivacaine

Brief summary

The most useful method to manage pain after major ankle surgery is infusion of local analgesics with a catheter close to the sciatic nerve. Sensation from the ankle are carried by three nerves: The tibial and peroneal nerve (unified in the sciatic nerve) and the saphenous nerve. Study purpose is to test whether continuous infusion of local analgesics by saphenous nerve catheter provide a better treatment of pain in comparison with a single injection nerve block. In addition cost-effectiveness of the two methods are compared. The 50 patients of the trial are randomized in clusters of ten. We intend to do a preliminary analysis of the data from the first 40 patients. However, it is not an interim analysis. Fifty patients will be included independent of the result of the preliminary analysis. The random allocation of the last 10 patients will also be double-blinded.

Detailed description

Major ankle surgery are known to be very painful the first 48 hours after the operation due to surgical oedema. This pain is difficult to control with systemic analgesics. Pain relief with systemic analgesics requires high doses of intravenous opioids and is associated with breakthrough pain and adverse effects of opioids (sedation, nausea, vomiting, obstipation, urinary retention, respiratory depression). Continuous, peripheral nerve block with catheter technique for two days minimizes the need for systemic analgesics. Today such a continuous sciatic nerve block is part of the standard pain treatment after major ankle surgery on Aarhus University Hospital. Despite accurate placement of the catheter many patients are in great pain because the saphenous nerve remain unaffected. A single injection block relieve the pain but a block with Ropivacaine only last 8-15 hours. Severe postoperative pain leads to high opioid dosages, cognitive blurring, nausea, vomiting, reduced ambulation, increased surgical stress response and increased morbidity. Pain problems and adverse effects prolongs postoperative observation time and maybe also time to discharge. The aim of the study establish whether continuous saphenous nerve block is efficient (pain relief or reduced opioid consumption) and justified (cost-effectiveness analysis) compared with single injection block.

Interventions

0,2% Ropivacaine by elastomeric infusion pump at 5 ml/h for 48 postoperative hours

PROCEDUREPlacebo

Isoton saline by elastomeric infusion pump at 5 ml/h for 48 postoperative hours

Sponsors

Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Elective major ankle surgery * total ankle arthroplasty * subtalar fusion * ankle fusion (non arthroscopic)

Exclusion criteria

* coagulation abnormalities * infection in the region of needle insertion * systemic infection * preoperative consumption of high dose opioid * preoperative sciatic or femoral nerve neuropathy * preoperative sensory deficit in either of the lower extremities * Charcot-Marie-Tooth disorder * diabetic neuropathy * severe peripheral vascular disease * allergy to local anesthetics * lack of understanding of Numeric Rank Scale (NRS) * communication problems * dementia * body mass index above 35 * bilateral continuous sciatic nerve block * lack of consent

Design outcomes

Primary

MeasureTime frame
Accumulated opioid consumptionFirst 48 hours postoperative

Secondary

MeasureTime frameDescription
Success rate for saphenous nerve analgesiaPostoperative, first 48 hoursPain rated by NRS and opioid consumption
Success rate for clinical analgesia of foot and anklePostoperative, first 48 hoursPain rated by NRS and opioid consumption
Success rate for tibial and peroneal nerve blockPostoperative, first 48 hoursPain rated by NRS and test of sensation on the toes
Localisation of worst painPostoperative, first 48 hours
Cost-effectiveness2 first postoperative days

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026